Sio Gene Therapies | SC 13G/A:超過5%持股股東披露文件(修正)-Suvretta Capital Management, LLC(0%),Averill Master Fund, Ltd.(0%)等
Sio Gene Therapies | SC 13G:超過5%持股股東披露文件-Rubric Capital Management LP(9.46%),David Rosen(9.46%)
Sio Gene Therapies | SC 13G/A:超過5%持股股東披露文件(修正)-Consonance Capital Management LP(0%),Mitchell Blutt(0%)等
Sio Gene Therapies | SC 13G/A:超過5%持股股東披露文件(修正)-Suvretta Capital Management, LLC(8.1%),Averill Master Fund, Ltd.(8.1%)等
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 3:首次持股聲明-首席商務官 Meswani Parag V
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
Sio Gene Therapies | 4:持股變動聲明
暫無數據